Cadence Pharmaceuticals, Inc. (CADX) – Analyst Ratings
-
Guggenheim Downgrades Cadence Pharma (CADX) to Neutral
-
Wedbush Downgrades Cadence Pharma (CADX) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CADX Stock Lookup